Apoglyx Competitors and Similar CompaniesClear all

Apoglyx's competitors and similar companies include Carmot Therapeutics, BIOTON and Viking Therapeutics.
Apoglyx
Apoglyx
Apoglyx is a biotech company developing a small molecule oral therapy for type 2 diabetes patients.
Carmot Therapeutics
Carmot Therapeutics
Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer.
BIOTON
BIOTON
Bioton is a biotech company whose major therapeutic area is diabetes.
Viking Therapeutics
Viking Therapeutics
Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of therapies for metabolic and endocrine disorders.
Founding Date
Founding Date
2015
Founding Date
2008
Founding Date
1989
Founding Date
2012
Type
Type
Private
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Malmö, SE HQ
Lund, SE
Locations
Berkeley, US HQ
Locations
Macierzysz, PL HQ
Locations
San Diego, US HQ
Employees
Employees
525% increase
Employees
109% decrease
Employees
361
Employees
2729% increase

Financial

Net income
Net income
N/A
Net income
($38.8m) (FY, 2022)
Net income
zł3.4m (FY, 2025)
Net income
($359.6m) (FY, 2025)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 74.8m
Total funding raised
N/A
Total funding raised
$ 15m
For sources of this data, please see the company profile

View Company Profiles

Carmot Therapeutics
HQ
Berkeley, US

Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer.

View company
BIOTON
HQ
Macierzysz, PL
Employees
361

Bioton is a biotech company whose major therapeutic area is diabetes.

View company
Viking Therapeutics
HQ
San Diego, US
Employees
27↑ 29% increase

Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of therapies for metabolic and endocrine disorders.

View company